MedTrace Logo

Acceptability of Human Papillomavirus (HPV) Self-sampling Tools for Cervical Cancer Prevention

NCT03613493 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 175

Last updated 2019-08-02

Study results available
· View outcomes & findings →

Summary

The proposed study aims to increase HPV screening behaviors in Jamaican women by examining the acceptability of HPV Deoxyribonucleic Acid (DNA) self-sampling tools, and to determine the most culturally appropriate and effective message design for promoting such a tool in this context.

Conditions

Interventions

DIAGNOSTIC_TEST

HPV self-sampling kit

The HPV self-sampler kit will include the collection swab and the vial for collecting and storing the specimen, and an instructional sheet that visually depicts the steps for self-sampling.

BEHAVIORAL

Culturally-targeted Fear Appeal Message

Participants will receive culturally-targeted and fear appeal messages in a graphically designed kit.

BEHAVIORAL

Fear Appeal Message

Participants will receive fear appeal messages (only) in a graphically designed kit.

BEHAVIORAL

Interview

Participants will be interviewed about experiences using the self-sampling tool (qualitative).

Sponsors & Collaborators

  • University of Miami

    lead OTHER

Principal Investigators

  • Susan E Morgan, PhD · University of Miami

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-07-10
Primary Completion
2018-10-01
Completion
2018-10-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03613493 on ClinicalTrials.gov